FDA Approved: ANASTROZOLE — Supplemental Application (Avet Pharmaceuticals Inc)

View source ↗

Summary

FDA approved a supplemental application for Avet Pharmaceuticals' anastrozole tablets (ANDA 206037), formalizing regulatory approval for this generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Anastrozole (Anastrozole)

Snippet

SUPPL AP for ANASTROZOLE (ANASTROZOLE TABLETS)